Suppr超能文献

小于 30 毫米的非小细胞肺癌实质和胸膜侵犯的生存。

Survival with Parenchymal and Pleural Invasion of Non-Small Cell Lung Cancers Less than 30 mm.

机构信息

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York.

Department of Diagnostic Ultrasound, Tong Ren Hospital, Capital Medical University, Beijing, People's Republic of China.

出版信息

J Thorac Oncol. 2019 May;14(5):890-902. doi: 10.1016/j.jtho.2019.01.013. Epub 2019 Jan 24.

Abstract

OBJECTIVE

To determine long-term survival of visceral pleural invasion (VPI) and parenchymal invasion (PAI) (angiolymphatic and/or vascular) on survival of NSCLCs less than 30 mm in maximum diameter.

METHODS

Kaplan-Meier survivals for NSCLCs, with and without VPI and/or PAI, were determined for a prospective cohort of screening participants stratified by pathologic tumor size (≤10 mm, 11-20 mm, and 21-30 mm) and nodule consistency. Log-rank test statistics were calculated.

RESULTS

The frequency of PAI versus VPI was significantly lower in patients with subsolid nodules than in those with solid nodules (4.9% versus 27.7% [p < 0.0001]), and correspondingly, Kaplan-Meier lung cancer survival was significantly higher among patients with subsolid nodules (99.1% versus 91.3% [p = 0.0009]). Multivariable Cox regression found that only tumor diameter (adjusted hazard ratio [HR] =1.07, 95% confidence interval [CI]: 1.01-1.14, p = 0.02) and PAI (adjusted HR = 3.15, 95% CI: 1.25-7.90, p = 0.01) remained significant, whereas VPI was not significant (p = 0.15). When clinical and computed tomography findings were included with the pathologic findings, Cox regression showed that the risk of dying of lung cancer increased 10-fold (HR = 10.06, 95% CI: 1.35-75.30) for NSCLCs in patients with solid nodules and more than twofold (by a factor of 2.27) in patients with moderate to severe emphysema (HR = 2.27, 95% CI: 1.01-5.11), as well as with increasing tumor diameter (HR = 1.06, 95% CI: 1.01-1.13), whereas PAI was no longer significant (p = 0.19).

CONCLUSIONS

Nodule consistency on computed tomography was a more significant prognostic indicator than either PAI or VPI. We propose that patients with NSCLC with VPI and a maximum tumor diameter of 30 mm or less not be upstaged to T2 without further large, multicenter studies of NSCLCs, stratified by the new T status and that classification be considered separately for patients with subsolid or solid nodules.

摘要

目的

确定最大直径小于 30mm 的非小细胞肺癌(NSCLC)中内脏胸膜侵犯(VPI)和实质侵犯(PAI)(血管淋巴管和/或血管)对生存的长期影响。

方法

对筛查参与者的前瞻性队列进行分析,根据病理肿瘤大小(≤10mm、11-20mm 和 21-30mm)和结节密度,对伴有和不伴有 VPI 和/或 PAI 的 NSCLC 进行 Kaplan-Meier 生存分析。计算对数秩检验统计量。

结果

与实性结节相比,亚实性结节中 PAI 发生率明显低于 VPI(4.9%对 27.7%[p<0.0001]),相应的,亚实性结节的肺癌生存率明显高于实性结节(99.1%对 91.3%[p=0.0009])。多变量 Cox 回归发现,只有肿瘤直径(调整后的危险比[HR]为 1.07,95%置信区间[CI]为 1.01-1.14,p=0.02)和 PAI(调整后的 HR 为 3.15,95%CI 为 1.25-7.90,p=0.01)仍然显著,而 VPI 不显著(p=0.15)。当临床和计算机断层扫描结果与病理结果结合时,Cox 回归显示,在实性结节患者中,死于肺癌的风险增加 10 倍(HR 为 10.06,95%CI 为 1.35-75.30),在中度至重度肺气肿患者中增加两倍(HR 为 2.27,95%CI 为 1.01-5.11),以及肿瘤直径增加(HR 为 1.06,95%CI 为 1.01-1.13),而 PAI 不再显著(p=0.19)。

结论

CT 结节密度是比 PAI 或 VPI 更重要的预后指标。我们建议,对于 VPI 最大肿瘤直径不超过 30mm 的 NSCLC 患者,除非有更大的、多中心的 NSCLC 研究进一步证实 T 分期的新分类,否则不应将其升级为 T2,且应分别对亚实性或实性结节患者进行分类。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验